Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001182183 | SCV001347539 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002068309 | SCV002346658 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2022-10-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491529 | SCV002798785 | likely benign | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2022-02-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001182183 | SCV003863099 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004008282 | SCV004823119 | likely benign | Marfan syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004720780 | SCV005331262 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | FBN1: BP4, BP7 |